SCHEMBL22708620

SCHEMBL22708620

c1ccc(-c2ccc3c(c2)oc2c4[nH]c5cc(N(c6ccccc6)c6ccccc6)ccc5c4c4ccccc4c32)cc1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CDK5 Q00535 4/20 0.37
▸ CDK5R1 Q15078 3/20 0.37
▸ DYRK1A Q13627 2/20 0.37
▸ GSK3A P49840 1/20 0.37
▸ GSK3B P49841 1/20 0.37
▸ MAP3K11 Q16584 2/20 0.34
▸ MAP3K9 P80192 1/20 0.34
▸ CDK4 P11802 2/20 0.33
▸ CCND1 P24385 2/20 0.33
▸ MEN1 O00255 2/20 0.33
▸ KMT2A Q03164 2/20 0.33
▸ KDM4E B2RXH2 1/20 0.33
▸ GAA P10253 1/20 0.33
▸ MAPT P10636 1/20 0.33
▸ TNKS2 Q9H2K2 1/20 0.32
▸ POLB P06746 1/20 0.31
▸ PPARG P37231 1/20 0.31
▸ RAB9A P51151 1/20 0.31
▸ NCOA2 Q15596 1/20 0.31
▸ NCOA1 Q15788 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22708549 0.86 CDK5 (0.49) CDK5CDK5R1DYRK1AGSK3AGSK3B
SCHEMBL19152326 0.83 CCNC (0.33) DYRK1AMEN1KMT2AKDM4EGAA
SCHEMBL22708929 0.83 MAP3K11 (0.44) CDK5CDK5R1DYRK1AGSK3AGSK3B
SCHEMBL13508218 0.83 KDM4E (0.34) DYRK1AMEN1KMT2AKDM4EGAA
SCHEMBL20845453 0.82 CCNC (0.35) DYRK1AMEN1KMT2AKDM4EGAA
SCHEMBL13508110 0.82 TDP1 (0.34) DYRK1AMEN1KMT2AKDM4EGAA
SCHEMBL24527214 0.81 KDM4E (0.34) DYRK1AMEN1KMT2AKDM4EGAA
SCHEMBL22708728 0.80 CDK5 (0.46) CDK5CDK5R1DYRK1AGSK3AGSK3B
SCHEMBL17658482 0.80 PLA2G2A (0.35) DYRK1AMEN1KMT2AKDM4EGAA
SCHEMBL17658495 0.80 CCNC (0.34) DYRK1AMEN1KMT2AKDM4EGAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11588110-B2 Heterocyclic compound and organic light emitting device comprising the same LT MATERIALS CO., LTD. (KR) 2023-02-21 — — US disclosed
US-20200373499-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING DEVICE COMPRISING THE SAME LT MATERIALS CO., LTD. (KR) 2020-11-26 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11588110-B2 Heterocyclic compound and organic light emitting device comprising the same CRY1, CYP1A1, CYP1B1 CDK5 1153/4885CDK5R1 1474/4885DYRK1A 4621/4885
US-20200373499-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING DEVICE COMPRISING THE SAME CRY1, CYP1A1, CYP1B1 CDK5 1153/4885CDK5R1 1474/4885DYRK1A 4621/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback